The U.S. Supreme Court voted last week on whether or not it would hear one or more of three separate cases involving issues related to subject matter eligibility under U.S. Patent Laws.
As noted in last weeks blog, the cases in which Petitions for Certiorari were under consideration were: HP Inc. v. Berkheimer; Hikma Pharmaceuticals USA Inc. et al. v. Vanda Pharmaceuticals USA, Inc.; and Athena Diagnostics, Inc. v. Mayo Collaborative Services, LLC.
The Court denied the petitions for cert in each of the cases, without opinion.